Informations sur le produit
- Fluindostatin
- XU 62-320
- Lescol
- Lipaxan
- Primexin
- (4R,6S)-6-[(1E)-2-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-one
- [4R-[4α,6β(E)]]-6-[2-[3-(4-Fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-one
- (4R,6S)-6-((E)-2-(3-(4-Fluorophenyl)-1-isopropyl-1H-indol-2-yl)vinyl)-4-hydroxytetrahydro-2H-pyran-2-one
Applications A synthetic HMG-CoA reductase inhibitor.
References Yuan, J., et al.: Atherosclerosis, 87, 147 (1991), Tse, F.L.S., et al.: J. Clin. Pharmacol., 32, 630 (1992), Dain, J.G., et al.: Drug Metab. Disposit., 21, 567 (1993),